411 related articles for article (PubMed ID: 17665462)
1. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
Schmajuk G; Schneeweiss S; Katz JN; Weinblatt ME; Setoguchi S; Avorn J; Levin R; Solomon DH
Arthritis Rheum; 2007 Aug; 57(6):928-34. PubMed ID: 17665462
[TBL] [Abstract][Full Text] [Related]
2. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
[TBL] [Abstract][Full Text] [Related]
4. Patterns of drug use in rheumatoid arthritis.
Bérard A; Solomon DH; Avorn J
J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
7. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
[TBL] [Abstract][Full Text] [Related]
8. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
[TBL] [Abstract][Full Text] [Related]
9. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
10. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy.
Yazici Y; Shi N; John A
Bull NYU Hosp Jt Dis; 2008; 66(2):77-85. PubMed ID: 18537774
[TBL] [Abstract][Full Text] [Related]
11. [Descriptive study of the use of DMARD in patients with rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)].
Blanco FJ; Ballina J; Carbonell J; Martín-Mola E; Tornero J; Ramírez E; Galván J
Reumatol Clin; 2011; 7(2):88-93. PubMed ID: 21794790
[TBL] [Abstract][Full Text] [Related]
12. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
13. Gaps in care for rheumatoid arthritis: a population study.
Lacaille D; Anis AH; Guh DP; Esdaile JM
Arthritis Rheum; 2005 Apr; 53(2):241-8. PubMed ID: 15818655
[TBL] [Abstract][Full Text] [Related]
14. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.
Setoguchi S; Solomon DH; Weinblatt ME; Katz JN; Avorn J; Glynn RJ; Cook EF; Carney G; Schneeweiss S
Arthritis Rheum; 2006 Sep; 54(9):2757-64. PubMed ID: 16947774
[TBL] [Abstract][Full Text] [Related]
16. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
[TBL] [Abstract][Full Text] [Related]
17. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
Ward MM; Fries JF
J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
[TBL] [Abstract][Full Text] [Related]
18. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
19. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
[TBL] [Abstract][Full Text] [Related]
20. Patterns of medication use during pregnancy in rheumatoid arthritis.
Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]